Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novanta (NOVT) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Novanta (NOVT) over the last 17 years, with Q3 2025 value amounting to $533000.0.

  • Novanta's Gains from Investment Securities rose 74603.17% to $533000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $8.5 million, marking a year-over-year decrease of 866.25%. This contributed to the annual value of $9.7 million for FY2024, which is 804.7% down from last year.
  • Per Novanta's latest filing, its Gains from Investment Securities stood at $533000.0 for Q3 2025, which was up 74603.17% from $518000.0 recorded in Q2 2025.
  • Over the past 5 years, Novanta's Gains from Investment Securities peaked at $18.3 million during Q2 2021, and registered a low of $63000.0 during Q3 2024.
  • Moreover, its 5-year median value for Gains from Investment Securities was $533000.0 (2025), whereas its average is $3.7 million.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first surged by 324535.52% in 2021, then tumbled by 9878.31% in 2022.
  • Over the past 5 years, Novanta's Gains from Investment Securities (Quarter) stood at $158000.0 in 2021, then skyrocketed by 1225.95% to $2.1 million in 2022, then plummeted by 81.29% to $392000.0 in 2023, then skyrocketed by 101.28% to $789000.0 in 2024, then tumbled by 32.45% to $533000.0 in 2025.
  • Its Gains from Investment Securities stands at $533000.0 for Q3 2025, versus $518000.0 for Q2 2025 and $6.7 million for Q1 2025.